Related Experiment Video
Updated: Nov 30, 2025

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Anticonvulsant mechanisms of the ketogenic diet and caloric restriction
Luna Rudy1, Rubio Carmen1, Rojas Daniel2
1Departamento de Neurofisiología, Instituto Nacional de Neurología y Neurocirugía, M.V.S. México City, Mexico.
Abstract:
Many treatments have been proposed to control epileptic seizures, such as the ketogenic diet and caloric restriction. However, seizure control has not yet been improved completely in all patients. Probably, due to the lack of understanding regarding this neurological disorder pathogenesis or pathophysiology, including its molecular approach. Currently, there is not much information about the molecular processes and genes involved, and their relation to the possible beneficial effects of diet therapy on epilepsy. The ketogenic diet and caloric restriction are implicated in potential anti-seizure mechanisms related to the gut microbiome, metabolic pathways, hormones and neurotransmitters, mitochondria improvement, a role in inflammation, and oxidative stress, among others. In this review, we pretend to describe the molecular mechanism and the possible genes involved in the different ketogenic diet and caloric restriction mechanisms of action described to decrease neural excitability and, therefore, epileptic seizures, especially when conventional treatment is not enough to achieve control of epilepsy.
Insights
Dietary interventions like the ketogenic diet and caloric restriction show promise for controlling epileptic seizures by influencing molecular pathways. Understanding these mechanisms and involved genes can improve epilepsy treatment when conventional methods fail.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Epilepsy treatment remains challenging, with many patients not achieving complete seizure control.
- The molecular underpinnings of epilepsy and the precise mechanisms of dietary interventions are not fully understood.
- Conventional therapies are insufficient for all individuals with epilepsy.
Purpose of the Study:
- To review the molecular mechanisms and genes involved in the anti-seizure effects of the ketogenic diet and caloric restriction.
- To explore how these dietary strategies impact neural excitability.
- To provide insights into novel therapeutic approaches for refractory epilepsy.
Main Methods:
- Literature review of studies on ketogenic diet, caloric restriction, and epilepsy.
- Analysis of molecular pathways, including gut microbiome, metabolism, and inflammation.
- Identification of potential genes associated with dietary intervention efficacy.
Main Results:
- Ketogenic diet and caloric restriction modulate gut microbiome, metabolic pathways, hormones, neurotransmitters, mitochondria, inflammation, and oxidative stress.
- These interventions show potential anti-seizure effects by reducing neural excitability.
- Specific molecular targets and genes are implicated in these beneficial effects.
Conclusions:
- Dietary interventions offer promising avenues for epilepsy management, particularly for treatment-resistant cases.
- Further research into the molecular mechanisms and genetic factors is crucial for optimizing these therapies.
- Understanding these pathways can lead to more personalized and effective epilepsy treatments.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

